WILSON TROY EDWARD
SEC Form 4 insider trading activity
WILSON TROY EDWARD has filed 10 SEC Form 4 filings (15 transaction rows) across 3 companies, including PBYI, KURA, RNAM, with disclosures dating back to 2025. 8 of those filings fall inside the rolling window. Most recent filing: Sep 17, 2026.
On the most recent filing, WILSON TROY EDWARD is listed as Director at PUMA BIOTECHNOLOGY, INC. Inside the rolling window, WILSON TROY EDWARD reported 2 open-market purchases totaling $2.4M in KURA and 3 open-market sales totaling $451K in PBYI and KURA. The largest disclosed transaction in the window is a purchase of 100,000 KURA shares on Aug 24, 2026, worth $1.2M.
Companies traded
Other insiders at PBYI
Insider Buying
$2.4M
reported purchases (SEC code P)
Insider Selling
$451K
reported sales (SEC code S)
Companies
3
in the rolling window
Earlier trades
Open-market purchases and sales filed before the rolling 365-day window, kept from the original Form 4 filings.
Frequently asked questions
How many SEC Form 4 filings has WILSON TROY EDWARD made?
WILSON TROY EDWARD has filed 10 SEC Form 4 filings (15 transaction rows) across 3 companies, including PBYI, KURA, RNAM since 2025.
Which companies does WILSON TROY EDWARD trade?
WILSON TROY EDWARD has filed SEC Form 4 disclosures for 3 companies, including PBYI, KURA, RNAM.
When was WILSON TROY EDWARD's most recent SEC Form 4 filing?
WILSON TROY EDWARD's most recent SEC Form 4 filing on Tracefour is dated Sep 17, 2026.
What is WILSON TROY EDWARD's total buy and sell value in the current window?
Inside the rolling retention window, WILSON TROY EDWARD bought $2.4M and sold $451K based on SEC Form 4 filings.
What was WILSON TROY EDWARD's largest disclosed transaction?
The largest disclosed transaction in the current window is a purchase of 100,000 KURA shares on 2026-08-24, worth $1.2M, per SEC Form 4 filings.